ID   UBP13_HUMAN             Reviewed;         863 AA.
AC   Q92995; A8K2S3; B4DYF3; D3DNS2; Q96B25;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   12-APR-2017, entry version 150.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 13;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 13;
DE   AltName: Full=Isopeptidase T-3;
DE            Short=ISOT-3;
DE   AltName: Full=Ubiquitin thioesterase 13;
DE   AltName: Full=Ubiquitin-specific-processing protease 13;
GN   Name=USP13; Synonyms=ISOT3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9841226; DOI=10.1016/S0378-1119(98)00341-2;
RA   Timms K.M., Ansari-Lari M.A., Morris W., Brown S.N., Gibbs R.A.;
RT   "The genomic organization of Isopeptidase T-3 (ISOT-3), a new member
RT   of the ubiquitin specific protease family (UBP).";
RL   Gene 217:101-106(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=17653289; DOI=10.1371/journal.pone.0000679;
RA   Catic A., Fiebiger E., Korbel G.A., Blom D., Galardy P.J.,
RA   Ploegh H.L.;
RT   "Screen for ISG15-crossreactive deubiquitinases.";
RL   PLoS ONE 2:E679-E679(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-122, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114 AND THR-122, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=21962518; DOI=10.1016/j.cell.2011.08.037;
RA   Liu J., Xia H., Kim M., Xu L., Li Y., Zhang L., Cai Y., Norberg H.V.,
RA   Zhang T., Furuya T., Jin M., Zhu Z., Wang H., Yu J., Li Y., Hao Y.,
RA   Choi A., Ke H., Ma D., Yuan J.;
RT   "Beclin1 controls the levels of p53 by regulating the deubiquitination
RT   activity of USP10 and USP13.";
RL   Cell 147:223-234(2011).
RN   [11]
RP   FUNCTION, INTERACTION WITH SIAH2, AND MUTAGENESIS OF TRP-221; LYS-233;
RP   PHE-273; CYS-345; MET-664; MET-739; HIS-814 AND HIS-823.
RX   PubMed=21659512; DOI=10.1074/jbc.M111.218214;
RA   Scortegagna M., Subtil T., Qi J., Kim H., Zhao W., Gu W., Kluger H.,
RA   Ronai Z.A.;
RT   "USP13 enzyme regulates Siah2 ligase stability and activity via
RT   noncatalytic ubiquitin-binding domains.";
RL   J. Biol. Chem. 286:27333-27341(2011).
RN   [12]
RP   FUNCTION, AND MUTAGENESIS OF CYS-345.
RX   PubMed=21811243; DOI=10.1038/ncomms1421;
RA   Zhao X., Fiske B., Kawakami A., Li J., Fisher D.E.;
RT   "Regulation of MITF stability by the USP13 deubiquitinase.";
RL   Nat. Commun. 2:414-414(2011).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH UFD1.
RX   PubMed=21571647; DOI=10.1073/pnas.1100028108;
RA   Chen M., Gutierrez G.J., Ronai Z.A.;
RT   "Ubiquitin-recognition protein Ufd1 couples the endoplasmic reticulum
RT   (ER) stress response to cell cycle control.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:9119-9124(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-122, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH AMFR; BAG6 AND UBL4A.
RX   PubMed=24424410; DOI=10.7554/eLife.01369;
RA   Liu Y., Soetandyo N., Lee J.G., Liu L., Xu Y., Clemons W.M. Jr.,
RA   Ye Y.;
RT   "USP13 antagonizes gp78 to maintain functionality of a chaperone in
RT   ER-associated degradation.";
RL   Elife 3:E01369-E01369(2014).
RN   [16]
RP   STRUCTURE BY NMR OF 188-301 AND 652-777, FUNCTION, DOMAIN, AND
RP   UBIQUITIN-BINDING.
RX   PubMed=22216260; DOI=10.1371/journal.pone.0029362;
RA   Zhang Y.H., Zhou C.J., Zhou Z.R., Song A.X., Hu H.Y.;
RT   "Domain analysis reveals that a deubiquitinating enzyme USP13 performs
RT   non-activating catalysis for Lys63-linked polyubiquitin.";
RL   PLoS ONE 6:E29362-E29362(2011).
CC   -!- FUNCTION: Deubiquitinase that mediates deubiquitination of target
CC       proteins such as BECN1, MITF, SKP2 and USP10 and is involved in
CC       various processes such as autophagy and endoplasmic reticulum-
CC       associated degradation (ERAD). Component of a regulatory loop that
CC       controls autophagy and p53/TP53 levels: mediates deubiquitination
CC       of BECN1, a key regulator of autophagy, leading to stabilize the
CC       PIK3C3/VPS34-containing complexes. Also deubiquitinates USP10, an
CC       essential regulator of p53/TP53 stability. In turn, PIK3C3/VPS34-
CC       containing complexes regulate USP13 stability, suggesting the
CC       existence of a regulatory system by which PIK3C3/VPS34-containing
CC       complexes regulate p53/TP53 protein levels via USP10 and USP13.
CC       Recruited by nuclear UFD1 and mediates deubiquitination of SKP2,
CC       thereby regulating endoplasmic reticulum-associated degradation
CC       (ERAD). Also regulates ERAD through the deubiquitination of UBL4A
CC       a component of the BAG6/BAT3 complex. Mediates stabilization of
CC       SIAH2 independently of deubiquitinase activity: binds
CC       ubiquitinated SIAH2 and acts by impairing SIAH2
CC       autoubiquitination. Has a weak deubiquitinase activity in vitro
CC       and preferentially cleaves 'Lys-63'-linked polyubiquitin chains.
CC       In contrast to USP5, it is not able to mediate unanchored
CC       polyubiquitin disassembly. Able to cleave ISG15 in vitro; however,
CC       additional experiments are required to confirm such data.
CC       {ECO:0000269|PubMed:17653289, ECO:0000269|PubMed:21571647,
CC       ECO:0000269|PubMed:21659512, ECO:0000269|PubMed:21811243,
CC       ECO:0000269|PubMed:21962518, ECO:0000269|PubMed:22216260,
CC       ECO:0000269|PubMed:24424410}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC   -!- ENZYME REGULATION: Specifically inhibited by spautin-1 (specific
CC       and potent autophagy inhibitor-1), a derivative of MBCQ that binds
CC       to USP13 and inhibits deubiquitinase activity. Regulated by
CC       PIK3C3/VPS34-containing complexes. The weak deubiquitinase
CC       activity in vitro suggests the existence of some mechanism that
CC       activates the enzyme. {ECO:0000269|PubMed:21962518}.
CC   -!- SUBUNIT: Interacts with UFD1. Interacts (via UBA domains) with
CC       SIAH2 (when ubiquitinated). Interacts with BAG6; the interaction
CC       is direct and may mediate UBL4A deubiquitination
CC       (PubMed:24424410). Interacts (via UBA 2 domain) with AMFR; the
CC       interaction is direct (PubMed:24424410). Interacts with UBL4A; may
CC       be indirect via BAG6 (PubMed:24424410).
CC       {ECO:0000269|PubMed:21571647, ECO:0000269|PubMed:21659512,
CC       ECO:0000269|PubMed:24424410}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92995-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92995-2; Sequence=VSP_043954;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in ovary and testes.
CC   -!- DOMAIN: The UBP-type zinc finger has lost its ability to bind
CC       ubiquitin and USP13 is not activated by unanchored ubiquitin.
CC       Swapping with the UBP-type zinc finger from USP5 restores ability
CC       to bind unanchored ubiquitin and subsequent activation of the
CC       protein (PubMed:22216260). {ECO:0000269|PubMed:22216260}.
CC   -!- DOMAIN: The UBA domains mediate binding to ubiquitin.
CC       {ECO:0000269|PubMed:22216260}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U75362; AAC63405.1; -; mRNA.
DR   EMBL; AK290338; BAF83027.1; -; mRNA.
DR   EMBL; AK302404; BAG63715.1; -; mRNA.
DR   EMBL; AC007687; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC125604; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78383.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78384.1; -; Genomic_DNA.
DR   EMBL; BC016146; AAH16146.1; -; mRNA.
DR   CCDS; CCDS3235.1; -. [Q92995-1]
DR   RefSeq; NP_003931.2; NM_003940.2. [Q92995-1]
DR   UniGene; Hs.175322; -.
DR   PDB; 2L80; NMR; -; A=188-301.
DR   PDB; 2LBC; NMR; -; A=652-777.
DR   PDBsum; 2L80; -.
DR   PDBsum; 2LBC; -.
DR   ProteinModelPortal; Q92995; -.
DR   SMR; Q92995; -.
DR   BioGrid; 114465; 49.
DR   DIP; DIP-53511N; -.
DR   IntAct; Q92995; 31.
DR   MINT; MINT-1195142; -.
DR   STRING; 9606.ENSP00000263966; -.
DR   BindingDB; Q92995; -.
DR   ChEMBL; CHEMBL3407324; -.
DR   MEROPS; C19.012; -.
DR   iPTMnet; Q92995; -.
DR   PhosphoSitePlus; Q92995; -.
DR   BioMuta; USP13; -.
DR   DMDM; 209572692; -.
DR   EPD; Q92995; -.
DR   MaxQB; Q92995; -.
DR   PaxDb; Q92995; -.
DR   PeptideAtlas; Q92995; -.
DR   PRIDE; Q92995; -.
DR   DNASU; 8975; -.
DR   Ensembl; ENST00000263966; ENSP00000263966; ENSG00000058056. [Q92995-1]
DR   Ensembl; ENST00000496897; ENSP00000417146; ENSG00000058056. [Q92995-2]
DR   GeneID; 8975; -.
DR   KEGG; hsa:8975; -.
DR   UCSC; uc003fkh.4; human. [Q92995-1]
DR   CTD; 8975; -.
DR   DisGeNET; 8975; -.
DR   GeneCards; USP13; -.
DR   H-InvDB; HIX0003883; -.
DR   HGNC; HGNC:12611; USP13.
DR   HPA; HPA004827; -.
DR   MIM; 603591; gene.
DR   neXtProt; NX_Q92995; -.
DR   OpenTargets; ENSG00000058056; -.
DR   PharmGKB; PA37237; -.
DR   eggNOG; KOG0944; Eukaryota.
DR   eggNOG; COG5207; LUCA.
DR   GeneTree; ENSGT00390000000874; -.
DR   HOGENOM; HOG000162311; -.
DR   HOVERGEN; HBG002833; -.
DR   InParanoid; Q92995; -.
DR   KO; K11836; -.
DR   OMA; MKEEHKP; -.
DR   OrthoDB; EOG091G01W3; -.
DR   PhylomeDB; Q92995; -.
DR   TreeFam; TF300576; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP13; human.
DR   GeneWiki; USP13; -.
DR   GenomeRNAi; 8975; -.
DR   PRO; PR:Q92995; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000058056; -.
DR   CleanEx; HS_USP13; -.
DR   ExpressionAtlas; Q92995; baseline and differential.
DR   Genevisible; Q92995; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:1904288; F:BAT3 complex binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0051087; F:chaperone binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB.
DR   GO; GO:0070628; F:proteasome binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0043130; F:ubiquitin binding; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0044389; F:ubiquitin-like protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:1904454; F:ubiquitin-specific protease activity involved in positive regulation of ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0008283; P:cell proliferation; IMP:UniProtKB.
DR   GO; GO:1904378; P:maintenance of unfolded protein involved in ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0030318; P:melanocyte differentiation; TAS:UniProtKB.
DR   GO; GO:1904294; P:positive regulation of ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0035523; P:protein K29-linked deubiquitination; IDA:MGI.
DR   GO; GO:0044313; P:protein K6-linked deubiquitination; IDA:MGI.
DR   GO; GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IDA:UniProtKB.
DR   GO; GO:0010506; P:regulation of autophagy; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.30.40.10; -; 2.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like.
DR   InterPro; IPR016652; Ubiquitinyl_hydrolase.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   Pfam; PF00627; UBA; 2.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF02148; zf-UBP; 1.
DR   PIRSF; PIRSF016308; UBP; 1.
DR   SMART; SM00165; UBA; 2.
DR   SMART; SM00290; ZnF_UBP; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   PROSITE; PS50030; UBA; 2.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autophagy; Complete proteome;
KW   Hydrolase; Metal-binding; Phosphoprotein; Protease;
KW   Reference proteome; Repeat; Thiol protease; Ubl conjugation pathway;
KW   Zinc; Zinc-finger.
FT   CHAIN         1    863       Ubiquitin carboxyl-terminal hydrolase 13.
FT                                /FTId=PRO_0000080635.
FT   DOMAIN      336    861       USP.
FT   DOMAIN      652    693       UBA 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00212}.
FT   DOMAIN      727    767       UBA 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00212}.
FT   ZN_FING     209    281       UBP-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00502}.
FT   ACT_SITE    345    345       Nucleophile. {ECO:0000305}.
FT   ACT_SITE    823    823       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES     114    114       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     122    122       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692}.
FT   VAR_SEQ       1     65       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043954.
FT   MUTAGEN     221    221       W->A: Does not abolish ability to
FT                                stabilize SIAH2.
FT                                {ECO:0000269|PubMed:21659512}.
FT   MUTAGEN     233    233       K->A: Does not abolish ability to
FT                                stabilize SIAH2.
FT                                {ECO:0000269|PubMed:21659512}.
FT   MUTAGEN     273    273       F->A: Impairs ability to stabilize SIAH2.
FT                                {ECO:0000269|PubMed:21659512}.
FT   MUTAGEN     345    345       C->A: Abolishes deubiquitinating
FT                                activity. Does not abolish ability to
FT                                stabilize SIAH2. Does not abolish ability
FT                                to stabilize SIAH2; when associated with
FT                                A-814 and A-823.
FT                                {ECO:0000269|PubMed:21659512,
FT                                ECO:0000269|PubMed:21811243}.
FT   MUTAGEN     664    664       M->E: Impairs ability to stabilize SIAH2.
FT                                Abolishes ability to stabilize SIAH2;
FT                                when associated with E-739.
FT                                {ECO:0000269|PubMed:21659512}.
FT   MUTAGEN     739    739       M->E: Impairs ability to stabilize SIAH2.
FT                                Abolishes ability to stabilize SIAH2;
FT                                when associated with E-664.
FT                                {ECO:0000269|PubMed:21659512}.
FT   MUTAGEN     814    814       H->A: Does not abolish ability to
FT                                stabilize SIAH2; when associated with A-
FT                                345 and A-823.
FT                                {ECO:0000269|PubMed:21659512}.
FT   MUTAGEN     823    823       H->A: Does not abolish ability to
FT                                stabilize SIAH2; when associated with A-
FT                                345 and A-814.
FT                                {ECO:0000269|PubMed:21659512}.
FT   CONFLICT     96     96       V -> A (in Ref. 1; AAC63405).
FT                                {ECO:0000305}.
FT   CONFLICT    293    293       I -> V (in Ref. 2; BAF83027).
FT                                {ECO:0000305}.
FT   CONFLICT    305    305       L -> F (in Ref. 2; BAF83027).
FT                                {ECO:0000305}.
FT   CONFLICT    325    325       T -> A (in Ref. 2; BAF83027).
FT                                {ECO:0000305}.
FT   CONFLICT    338    338       L -> P (in Ref. 2; BAF83027).
FT                                {ECO:0000305}.
FT   TURN        191    194       {ECO:0000244|PDB:2L80}.
FT   STRAND      212    214       {ECO:0000244|PDB:2L80}.
FT   STRAND      217    223       {ECO:0000244|PDB:2L80}.
FT   TURN        224    226       {ECO:0000244|PDB:2L80}.
FT   STRAND      229    231       {ECO:0000244|PDB:2L80}.
FT   HELIX       244    251       {ECO:0000244|PDB:2L80}.
FT   STRAND      256    260       {ECO:0000244|PDB:2L80}.
FT   STRAND      269    272       {ECO:0000244|PDB:2L80}.
FT   TURN        273    275       {ECO:0000244|PDB:2L80}.
FT   STRAND      277    279       {ECO:0000244|PDB:2L80}.
FT   HELIX       284    290       {ECO:0000244|PDB:2L80}.
FT   HELIX       296    299       {ECO:0000244|PDB:2L80}.
FT   HELIX       656    662       {ECO:0000244|PDB:2LBC}.
FT   HELIX       669    678       {ECO:0000244|PDB:2LBC}.
FT   HELIX       683    692       {ECO:0000244|PDB:2LBC}.
FT   HELIX       693    695       {ECO:0000244|PDB:2LBC}.
FT   STRAND      697    700       {ECO:0000244|PDB:2LBC}.
FT   STRAND      710    714       {ECO:0000244|PDB:2LBC}.
FT   HELIX       730    739       {ECO:0000244|PDB:2LBC}.
FT   HELIX       743    753       {ECO:0000244|PDB:2LBC}.
FT   HELIX       757    765       {ECO:0000244|PDB:2LBC}.
SQ   SEQUENCE   863 AA;  97327 MW;  988713ADF8C0B938 CRC64;
     MQRRGALFGM PGGSGGRKMA AGDIGELLVP HMPTIRVPRS GDRVYKNECA FSYDSPNSEG
     GLYVCMNTFL AFGREHVERH FRKTGQSVYM HLKRHVREKV RGASGGALPK RRNSKIFLDL
     DTDDDLNSDD YEYEDEAKLV IFPDHYEIAL PNIEELPALV TIACDAVLSS KSPYRKQDPD
     TWENELPVSK YANNLTQLDN GVRIPPSGWK CARCDLRENL WLNLTDGSVL CGKWFFDSSG
     GNGHALEHYR DMGYPLAVKL GTITPDGADV YSFQEEEPVL DPHLAKHLAH FGIDMLHMHG
     TENGLQDNDI KLRVSEWEVI QESGTKLKPM YGPGYTGLKN LGNSCYLSSV MQAIFSIPEF
     QRAYVGNLPR IFDYSPLDPT QDFNTQMTKL GHGLLSGQYS KPPVKSELIE QVMKEEHKPQ
     QNGISPRMFK AFVSKSHPEF SSNRQQDAQE FFLHLVNLVE RNRIGSENPS DVFRFLVEER
     IQCCQTRKVR YTERVDYLMQ LPVAMEAATN KDELIAYELT RREAEANRRP LPELVRAKIP
     FSACLQAFSE PENVDDFWSS ALQAKSAGVK TSRFASFPEY LVVQIKKFTF GLDWVPKKFD
     VSIDMPDLLD INHLRARGLQ PGEEELPDIS PPIVIPDDSK DRLMNQLIDP SDIDESSVMQ
     LAEMGFPLEA CRKAVYFTGN MGAEVAFNWI IVHMEEPDFA EPLTMPGYGG AASAGASVFG
     ASGLDNQPPE EIVAIITSMG FQRNQAIQAL RATNNNLERA LDWIFSHPEF EEDSDFVIEM
     ENNANANIIS EAKPEGPRVK DGSGTYELFA FISHMGTSTM SGHYICHIKK EGRWVIYNDH
     KVCASERPPK DLGYMYFYRR IPS
//
